Wedelolactone

Wedelolactone is a lipid of Polyketides (PK) class. Wedelolactone is associated with abnormalities such as CLEFT LIP, CONGENITAL HEALED and Hepatitis. The involved functions are known as Signal Transduction, Cell Cycle Arrest, Apoptosis, luciferase activity and Metabolic Inhibition. Wedelolactone often locates in Protoplasm and Smooth muscle (tissue). The associated genes with Wedelolactone are CFB gene, Candidate Disease Gene, JAK2 gene, STAT2 gene and STAT3 gene.

Cross Reference

Introduction

To understand associated biological information of Wedelolactone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Wedelolactone?

Wedelolactone is suspected in CLEFT LIP, CONGENITAL HEALED, Hepatitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Wedelolactone

PubChem Associated disorders and diseases

What pathways are associated with Wedelolactone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Wedelolactone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Wedelolactone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Wedelolactone?

There are no associated biomedical information in the current reference collection.

What genes are associated with Wedelolactone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Wedelolactone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Wedelolactone

Download all related citations
Per page 10 20 50 100 | Total 111
Authors Title Published Journal PubMed Link
pmid:
da Silva AJM PA et al. Synthesis and preliminary pharmacological evaluation of coumestans with different patterns of oxygenation. 2001 Bioorg. Med. Chem. Lett. pmid:11212092
Lans C et al. Medicinal and ethnoveterinary remedies of hunters in Trinidad. 2001 BMC Complement Altern Med pmid:11737880
Syed SD et al. Trypsin inhibitory effect of wedelolactone and demethylwedelolactone. 2003 Phytother Res pmid:12722155
Kobori M et al. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. 2004 Cell Death Differ. pmid:14526390
Li CC et al. Total synthesis of wedelolactone. 2003 J. Org. Chem. pmid:14575477
Jayathirtha MG and Mishra SH Preliminary immunomodulatory activities of methanol extracts of Eclipta alba and Centella asiatica. 2004 Phytomedicine pmid:15185851
Jayathirtha MG and Mishra SH Optimization of wedelolactone accumulation in shoot cultures of Eclipta alba. 2003 Indian J. Exp. Biol. pmid:15320508
Annie S et al. Activity of Wedelia calendulacea Less. in post-menopausal osteoporosis. 2006 Phytomedicine pmid:16360932
Ruhland A et al. Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis. 2007 Cell. Microbiol. pmid:16889626
Pôças ES et al. Structure-activity relationship of wedelolactone analogues: structural requirements for inhibition of Na+, K+ -ATPase and binding to the central benzodiazepine receptor. 2006 Bioorg. Med. Chem. pmid:16945543
Markovic D et al. The onset of labor alters corticotropin-releasing hormone type 1 receptor variant expression in human myometrium: putative role of interleukin-1beta. 2007 Endocrinology pmid:17431005
Tewtrakul S et al. HIV-1 protease and HIV-1 integrase inhibitory substances from Eclipta prostrata. 2007 Phytother Res pmid:17696192
Lin FM et al. Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells. 2007 Carcinogenesis pmid:17942463
Fedorov O et al. A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:18077363
Radhakrishnan P et al. Cell type-specific activation of the cytomegalovirus promoter by dimethylsulfoxide and 5-aza-2'-deoxycytidine. 2008 Int. J. Biochem. Cell Biol. pmid:18373939
Li X et al. Action of fibroblast growth factor-2 on the intervertebral disc. 2008 Arthritis Res. Ther. pmid:18435858
Hammadi A et al. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation. 2008 Nitric Oxide pmid:18474259
Roy RK et al. Hair growth promoting activity of Eclipta alba in male albino rats. 2008 Arch. Dermatol. Res. pmid:18478241
Bremer E et al. Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells. 2008 J. Mol. Med. pmid:18504532
Agbottah E et al. Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways. 2008 AIDS Res Ther pmid:18544167
Vender JR et al. Inhibition of NFkappaB reduces cellular viability in GH3 pituitary adenoma cells. 2008 Neurosurgery pmid:18580810
Lim JH et al. CYLD is a crucial negative regulator of innate immune response in Escherichia coli pneumonia. 2008 Cell. Microbiol. pmid:18643924
Xu CB et al. Lipid-soluble smoke particles upregulate vascular smooth muscle ETB receptors via activation of mitogen-activating protein kinases and NF-kappaB pathways. 2008 Toxicol. Sci. pmid:18718921
Malara N et al. Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells. 2008 Cell Cycle pmid:18931595
Mohan S et al. High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction. 2009 Am. J. Physiol., Cell Physiol. pmid:18945937
Rawal RK et al. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives. 2008 Bioorg. Med. Chem. Lett. pmid:18947995
Zimmermann TJ et al. Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone. 2009 Bioorg. Med. Chem. pmid:19097799
Diogo LC et al. Inhibition of snake venoms and phospholipases A(2) by extracts from native and genetically modified Eclipta alba: isolation of active coumestans. 2009 Basic Clin. Pharmacol. Toxicol. pmid:19320636
Tanabe K et al. Mechanisms of interleukin-1beta-induced GDNF release from rat glioma cells. 2009 Brain Res. pmid:19362079
Lefas G and Chaconas G High-throughput screening identifies three inhibitor classes of the telomere resolvase from the lyme disease spirochete. 2009 Antimicrob. Agents Chemother. pmid:19596868
Idris AI et al. Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo. 2009 Mol. Cancer Ther. pmid:19671767
Tsai CH et al. Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice. 2009 Clin. Cancer Res. pmid:19690196
Rowe DL et al. Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin. 2009 Breast Cancer (Auckl) pmid:19809577
Melo PA et al. Ability of a synthetic coumestan to antagonize Bothrops snake venom activities. 2010 Feb-Mar Toxicon pmid:19883675
Tanabe K et al. Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells. 2010 J Neuroinflammation pmid:20205746
Huang LH et al. Lipid soluble smoke particles upregulate endothelin receptors in rat basilar artery. 2010 Toxicol. Lett. pmid:20561571
Yang JH et al. [Regulation of NF-κB signal transduction pathway on cytokines in cultured nasal epithelium]. 2010 Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:21055061
Chen QW et al. Cigarette smoke extract promotes human vascular smooth muscle cell proliferation and survival through ERK1/2- and NF-κB-dependent pathways. 2010 ScientificWorldJournal pmid:21057728
Maalouf SW et al. Inflammatory responses in epithelia: endotoxin-induced IL-6 secretion and iNOS/NO production are differentially regulated in mouse mammary epithelial cells. 2010 J Inflamm (Lond) pmid:21118556
Benes P et al. Inhibition of topoisomerase IIα: novel function of wedelolactone. 2011 Cancer Lett. pmid:21315506
Meley D et al. p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma. 2010 Cell Death Dis pmid:21364648
Patel MB et al. Simultaneous estimation of andrographolide and wedelolactone in herbal formulations. 2008 Indian J Pharm Sci pmid:21394279
Huston WM et al. Apoptosis is induced in Chlamydia trachomatis-infected HEp-2 cells by the addition of a combination innate immune activation compounds and the inhibitor wedelolactone. 2011 Am. J. Reprod. Immunol. pmid:21463376
Bharadwaj U et al. Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation. 2011 Carcinogenesis pmid:21515913
Rostelato-Ferreira S et al. Heparin at low concentration acts as antivenom against Bothrops jararacussu venom and bothropstoxin-I neurotoxic and myotoxic actions. 2010 J Venom Res pmid:21544183
Patrikidou A et al. Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells. 2011 Cancer Cell Int. pmid:21569620
Tanabe K et al. Midazolam suppresses interleukin-1β-induced interleukin-6 release from rat glial cells. 2011 J Neuroinflammation pmid:21682888
Sukumari-Ramesh S et al. Dietary phytochemicals induce p53- and caspase-independent cell death in human neuroblastoma cells. 2011 Int. J. Dev. Neurosci. pmid:21704149
Tseng CK et al. An in vitro coupled transcription/translation reporter system for hepatitis C virus RNA-dependent RNA polymerase. 2011 Anal. Biochem. pmid:21782784
Khameneh HJ et al. GM-CSF signalling boosts dramatically IL-1 production. 2011 PLoS ONE pmid:21829580
Bharadwaj U et al. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression. 2011 Mol. Cancer pmid:21880146
Zerbini LF et al. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy. 2011 PLoS ONE pmid:21931671
Prakash T et al. Neuroprotective activity of Wedelia calendulacea on cerebral ischemia/reperfusion induced oxidative stress in rats. 2011 Indian J Pharmacol pmid:22144773
Li J et al. Minimally modified LDL upregulates endothelin type B receptors in rat basilar artery. 2012 Microvasc. Res. pmid:22198335
Jie L et al. Minimally modified LDL upregulates endothelin type B receptors in rat coronary artery via ERK1/2 MAPK and NF-κB pathways. 2012 Biochim. Biophys. Acta pmid:22198514
Upadhyay K et al. Development and characterization of phyto-vesicles of wedelolactone for hepatoprotective activity. 2012 Drug Dev Ind Pharm pmid:22204306
Dos Santos JI et al. Structural and functional studies of a bothropic myotoxin complexed to rosmarinic acid: new insights into Lys49-PLAâ‚‚ inhibition. 2011 PLoS ONE pmid:22205953
Zhang W et al. Activation of nuclear factor-κB pathway is responsible for tumor necrosis factor-α-induced up-regulation of endothelin B2 receptor expression in vascular smooth muscle cells in vitro. 2012 Toxicol. Lett. pmid:22207076
Rance E et al. Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication. 2012 J. Viral Hepat. pmid:22239529
Gao W et al. Distinct regulation of host responses by ERK and JNK MAP kinases in swine macrophages infected with pandemic (H1N1) 2009 influenza virus. 2012 PLoS ONE pmid:22279582
Nichols DB et al. Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives. 2012 Eur J Med Chem pmid:22280819
Nanbara H et al. Modulation of Wnt5a expression by periodontopathic bacteria. 2012 PLoS ONE pmid:22485170
Deng H and Fang Y Anti-inflammatory gallic Acid and wedelolactone are G protein-coupled receptor-35 agonists. 2012 Pharmacology pmid:22488351
Kato K et al. AMPK limits IL-1-stimulated IL-6 synthesis in osteoblasts: involvement of IκB/NF-κB pathway. 2012 Cell. Signal. pmid:22560875
Lim S et al. Wedelolactone inhibits adipogenesis through the ERK pathway in human adipose tissue-derived mesenchymal stem cells. 2012 J. Cell. Biochem. pmid:22678810
He M et al. [Simultaneous determination of four compounds in Erzhiwan by HPLC]. 2012 Zhongguo Zhong Yao Za Zhi pmid:22693900
Benes P et al. Redox state alters anti-cancer effects of wedelolactone. 2012 Environ. Mol. Mutagen. pmid:22733624
Liu QM et al. Eclipta prostrata L. phytochemicals: isolation, structure elucidation, and their antitumor activity. 2012 Food Chem. Toxicol. pmid:22902823
Lee YJ et al. Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice. 2012 Eur J Med Chem pmid:22926226
Sarveswaran S et al. Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. 2012 Int. J. Oncol. pmid:23076676
Benedetti G et al. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells. 2013 Biochem. Pharmacol. pmid:23103562
Golub AG et al. Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors. 2012 Eur J Med Chem pmid:23127989
Lim WS et al. Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway. 2013 Cytokine pmid:23141142
Chen Z et al. Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation. 2013 J. Biol. Chem. pmid:23580655
Xia Y et al. Wedelolactone exhibits anti-fibrotic effects on human hepatic stellate cell line LX-2. 2013 Eur. J. Pharmacol. pmid:23791612
Patil AA et al. Optimization of sample preparation variables for wedelolactone from Eclipta alba using Box-Behnken experimental design followed by HPLC identification. 2013 Ann Pharm Fr pmid:23835023
Buldak RJ et al. Exogenous administration of visfatin affects cytokine secretion and increases oxidative stress in human malignant melanoma Me45 cells. 2013 J. Physiol. Pharmacol. pmid:23959735
Yuan F et al. Wedelolactone inhibits LPS-induced pro-inflammation via NF-kappaB pathway in RAW 264.7 cells. 2013 J. Biomed. Sci. pmid:24176090
Wong SM et al. Wedelolactone and coumestan derivatives as new antihepatotoxic and antiphlogistic principles. 1988 Arzneimittelforschung pmid:2458108
Xu D et al. The wedelolactone derivative inhibits estrogen receptor-mediated breast, endometrial, and ovarian cancer cells growth. 2014 Biomed Res Int pmid:25221777
Liu YQ et al. Inhibitory effect of Ecliptae herba extract and its component wedelolactone on pre-osteoclastic proliferation and differentiation. 2014 J Ethnopharmacol pmid:25267578
Hsieh CJ et al. Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling. 2015 Int. J. Oncol. pmid:25421824
Jayadeepa RM et al. Review and research analysis of computational target methods using BioRuby and in silico screening of herbal lead compounds against pancreatic cancer using R programming. 2014 Curr. Drug Metab. pmid:25431153
Snyder NW et al. 15-Oxoeicosatetraenoic acid is a 15-hydroxyprostaglandin dehydrogenase-derived electrophilic mediator of inflammatory signaling pathways. 2015 Chem. Biol. Interact. pmid:25450232
Lin WL et al. Ethyl acetate extract of Wedelia chinensis inhibits tert-butyl hydroperoxide-induced damage in PC12 cells and D-galactose-induced neuronal cell loss in mice. 2014 BMC Complement Altern Med pmid:25510435
Huang W et al. Caspase-11 plays an essential role in methamphetamine-induced dopaminergic neuron apoptosis. 2015 Toxicol. Sci. pmid:25631491
Nehybova T et al. Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling. 2015 J. Steroid Biochem. Mol. Biol. pmid:25934092
Chen H et al. Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer. 2015 Oncotarget pmid:25944687
Zhao Y et al. Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPARα/LPL and LDLR. 2015 PLoS ONE pmid:26168156
Ding S et al. Wedelolactone protects human bronchial epithelial cell injury against cigarette smoke extract-induced oxidant stress and inflammation responses through Nrf2 pathway. 2015 Int. Immunopharmacol. pmid:26411738
Fratantonio D et al. Palmitate-induced endothelial dysfunction is attenuated by cyanidin-3-O-glucoside through modulation of Nrf2/Bach1 and NF-κB pathways. 2015 Toxicol. Lett. pmid:26422990
Alquézar C et al. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers. 2016 J Psychiatry Neurosci pmid:26624524
Berrak Ö et al. The inhibition of PI3K and NFκB promoted curcumin-induced cell cycle arrest at G2/M via altering polyamine metabolism in Bcl-2 overexpressing MCF-7 breast cancer cells. 2016 Biomed. Pharmacother. pmid:26796279
Lu Y et al. Protective effect of wedelolactone against CCl4-induced acute liver injury in mice. 2016 Int. Immunopharmacol. pmid:26921731
Li L et al. Wedelolactone metabolism in rats through regioselective glucuronidation catalyzed by uridine diphosphate-glucuronosyltransferases 1As (UGT1As). 2016 Phytomedicine pmid:27002404
Ali F et al. Wedelolactone mitigates UVB induced oxidative stress, inflammation and early tumor promotion events in murine skin: plausible role of NFkB pathway. 2016 Eur. J. Pharmacol. pmid:27164422
Sarveswaran S et al. Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells. 2016 Mol. Cancer Ther. pmid:27474149
Liu YQ et al. Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway. 2016 Sci Rep pmid:27558652
Ferrari D et al. Cyanidin-3-O-glucoside inhibits NF-kB signalling in intestinal epithelial cells exposed to TNF-α and exerts protective effects via Nrf2 pathway activation. 2016 Toxicol. Lett. pmid:27793764